Patents by Inventor Namvar Kiaie
Namvar Kiaie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240095014Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.Type: ApplicationFiled: July 17, 2023Publication date: March 21, 2024Inventors: Namvar Kiaie, Jean-Pierre Cole
-
Publication number: 20240008769Abstract: An analyte monitoring system with a sensor control device including an electronics housing. The housing can include a shell disposed opposite a mount, each including an aperture which is axially aligned with the other aperture. The inner surfaces are aligned, and a seal is disposed within the interior space. The housing also includes a circuit board disposed within the interior space of the housing, and an analyte sensor having a proximal portion and a distal portion, the proximal portion coupled with the circuit board, and the distal portion configured to measure a glucose level in a bodily fluid and extending from a bottom of the electronics housing.Type: ApplicationFiled: July 11, 2023Publication date: January 11, 2024Applicant: ABBOTT DIABETES CARE INC.Inventors: Matthew Simmons, Steven Mitchell, Vivek Rao, Namvar Kiaie
-
Patent number: 11837358Abstract: Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.Type: GrantFiled: June 22, 2021Date of Patent: December 5, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Christopher V. Reggiardo, Namvar Kiaie, James Thomson
-
Publication number: 20230337976Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.Type: ApplicationFiled: June 22, 2023Publication date: October 26, 2023Inventors: Jean-Pierre COLE, Benjamin J. FELDMAN, Udo HOSS, Namvar KIAIE, Frederic T. ARBOGAST
-
Patent number: 11748088Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.Type: GrantFiled: November 1, 2021Date of Patent: September 5, 2023Assignee: ABBOTT DIABETES CARE INC.Inventors: Namvar Kiaie, Jean-Pierre Cole
-
Publication number: 20230268071Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: February 28, 2023Publication date: August 24, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Publication number: 20230238131Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: April 3, 2023Publication date: July 27, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Publication number: 20230128038Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 19, 2022Publication date: April 27, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230121367Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 19, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230121101Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230122702Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230121769Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 19, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230119512Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230123384Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230118818Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.Type: ApplicationFiled: December 20, 2022Publication date: April 20, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Benjamin J. FELDMAN, Mark K. SLOAN, Ashwin KUMAR, Namvar KIAIE, Michael R. LOVE
-
Publication number: 20230079165Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.Type: ApplicationFiled: November 10, 2022Publication date: March 16, 2023Inventors: Jean-Pierre COLE, Benjamin J. FELDMAN, Udo HOSS, Namvar KIAIE, Frederic T. Arbogast
-
Publication number: 20230064839Abstract: Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.Type: ApplicationFiled: November 10, 2022Publication date: March 2, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Christopher V. Reggiardo, Namvar Kiaie, James Thomson
-
Publication number: 20220409053Abstract: Embodiments described herein include a medical monitoring system with a cloud communication interface in which individual components of the medical monitoring system, including medical sensors and data receiving devices are configured to communicate with remote cloud servers of the medical monitoring system using cellular networks. The remote cloud servers process medical data reported by the medical sensors and deliver data to the data receiving devices. The components of the medical monitoring system are low-cost and durable. The sensors are considered disposable after the expiration of their active use lifetime. The data receiving device can be manufactured using low-cost durable components to be protected against loss caused by accidental damage, destruction, or misplacement. Embodiments described herein further provide for authentication and for secure communication among the components of the medical monitoring system.Type: ApplicationFiled: June 22, 2022Publication date: December 29, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Marc B. Taub, Namvar Kiaie
-
Publication number: 20220409052Abstract: Embodiments described herein include a medical monitoring system with a cloud communication interface in which individual components of the medical monitoring system, including medical sensors and data receiving devices are configured to communicate with remote cloud servers of the medical monitoring system using cellular networks. The remote cloud servers process medical data reported by the medical sensors and deliver data to the data receiving devices. The components of the medical monitoring system are low-cost and durable. The sensors are considered disposable after the expiration of their active use lifetime. The data receiving device can be manufactured using low-cost durable components to be protected against loss caused by accidental damage, destruction, or misplacement. Embodiments described herein further provide for authentication and for secure communication among the components of the medical monitoring system.Type: ApplicationFiled: June 22, 2022Publication date: December 29, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Marc B. Taub, Namvar Kiaie
-
Publication number: 20220386910Abstract: Methods and analyte sensors including at least a first working electrode having a first active area thereon, and performing a dip coating operation to deposit a bilayer membrane upon the first working electrode and the first active area. The bilayer may include an inner layer having a first membrane polymer and an outer layer having a second membrane polymer, the first membrane polymer and the second membrane polymer differing from one another. The dip coating operation may comprise one or more first dips in a first membrane formulation to form the inner layer of the bilayer membrane and one or more second dips in a second membrane formulation to form the outer layer of the bilayer membrane upon the inner layer.Type: ApplicationFiled: August 11, 2022Publication date: December 8, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Stephen OJA, Tianmei Ouyang, Hyun Cho, Lam N. Tran, Benjamin J. Feldman, Mark K. Sloan, AShwin Kumar, Namvar Kiaie, Michael R. Love